Browse

Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells

DC Field Value Language
dc.contributor.authorSong, Yoo-Cheol-
dc.contributor.authorKim, Su-Hyeong-
dc.contributor.authorJuhnn, Yong-Sung-
dc.contributor.authorSong, Yong-Sang-
dc.date.accessioned2010-01-08T08:38:54Z-
dc.date.available2010-01-08T08:38:54Z-
dc.date.issued2007-04-04-
dc.identifier.citationAnn N Y Acad Sci. 2007 Jan;1095:26-34.en
dc.identifier.issn0077-8923 (Print)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17404014-
dc.identifier.urihttp://hdl.handle.net/10371/29097-
dc.description.abstractCelecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, induces the apoptosis in various cancers in COX-2 dependent and/or independent manners. The p53 protein is mutated in 50% of all human tumors and plays a key role in apoptosis, cell cycle, and the expression of several proteins. In ovarian cancer, the rate of p53 mutation has been shown to be very high and associated with poor prognosis. To explore the importance of functional status of p53 in apoptosis by celecoxib in ovarian cancer cells, the cellular response to celecoxib was determined in SK-OV3 ovarian cancer cells with null type p53 and PA-1 with wild-type p53. Our results showed that celecoxib inhibited cell growth more in PA-1 than in SK-OV3. The underlying antiproliferative mechanism may differ between these two cell types dependent upon the functional status of p53, which plays integral roles in regulating cell cycle and survival. Higher sub-G1 was shown in PA-1 than in SK-OV3 in response to celecoxib (PA-1 versus SK-OV3; 60.28% versus 6.69%). Caspase -8, -9, and -3 were activated in PA-1 cells, but not in SK-OV3 cells. These results suggest that death receptor and mitochondria-mediated apoptotic pathways may be involved in celecoxib-induced apoptosis dependent upon the functional status of p53. Our article demonstrated that the celecoxib effectively inhibited cell growth and induced apoptosis in human ovarian cancer cells with wild-type p53. Thus, apoptotic effect by celecoxib seemed to be different dependent upon the functional status of p53.en
dc.language.isoenen
dc.publisherWiley-Blackwellen
dc.subjectAntineoplastic Agents/*pharmacologyen
dc.subjectApoptosis/*drug effects/physiologyen
dc.subjectCell Line, Tumoren
dc.subjectFemaleen
dc.subjectGrowth Inhibitors/*pharmacologyen
dc.subjectHumansen
dc.subjectNeoplasms, Glandular and Epithelial/drug therapy/metabolism/pathologyen
dc.subjectOvarian Neoplasms/*drug therapy/metabolism/*pathologyen
dc.subjectPyrazoles/*pharmacologyen
dc.subjectSulfonamides/*pharmacologyen
dc.subjectTumor Suppressor Protein p53/metabolism/*physiologyen
dc.titleApoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cellsen
dc.typeArticleen
dc.contributor.AlternativeAuthor송유철-
dc.contributor.AlternativeAuthor김수형-
dc.contributor.AlternativeAuthor전용성-
dc.contributor.AlternativeAuthor송용상-
dc.identifier.doi10.1196/annals.1397.004-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Program in Cancer Biology (협동과정-종양생물학전공)Journal Papers (저널논문_협동과정-종양생물학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse